Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study

Omer Linkovski; Michael G. Wheaton; Jordana Zwerling; Zagaa Odgerel; Peter Van Roessel; Maria Filippou-Frye; Anthony Lombardi; Brianna Wright; Shari A. Steinman; Helen Blair Simpson; Francis Lee; Carolyn I. Rodriguez

doi:10.1097/JCP.0000000000000994

Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study

Omer Linkovski
, Michael G. Wheaton
, Jordana Zwerling
, Zagaa Odgerel
, Peter Van Roessel
, Maria Filippou-Frye
, Anthony Lombardi
, Brianna Wright
, Shari A. Steinman
, Helen Blair Simpson
, Francis Lee
, Carolyn I. Rodriguez

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	91-93
Number of pages	3
Journal	Journal of Clinical Psychopharmacology
Volume	39
Issue number	1
DOIs	https://doi.org/10.1097/JCP.0000000000000994
State	Published - 1 Jan 2019
Externally published	Yes

Bibliographical note

Funding Information:
This study was supported by the National Institutes of Mental Health [K23MH092434 (Dr Rodriguez) and K24MH09155 (Dr Simpson)], the Robert Wood Johnson Foundation [Harold Amos Medical Faculty Development Program (Dr Rodriguez)], the Black Family Foundation, and the New York State Psychiatric Institute.

Funding

This study was supported by the National Institutes of Mental Health [K23MH092434 (Dr Rodriguez) and K24MH09155 (Dr Simpson)], the Robert Wood Johnson Foundation [Harold Amos Medical Faculty Development Program (Dr Rodriguez)], the Black Family Foundation, and the New York State Psychiatric Institute.

Funders	Funder number
Black Family Foundation
National Institutes of Mental Health	K24MH09155
National Institute of Mental Health	K23MH092434
Robert Wood Johnson Foundation
New York State Psychiatric Institute

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1097/JCP.0000000000000994

Cite this

Linkovski, O., Wheaton, M. G., Zwerling, J., Odgerel, Z., Van Roessel, P., Filippou-Frye, M., Lombardi, A., Wright, B., Steinman, S. A., Simpson, H. B., Lee, F., & Rodriguez, C. I. (2019). Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study. Journal of Clinical Psychopharmacology, 39(1), 91-93. https://doi.org/10.1097/JCP.0000000000000994

@article{e6d33a7aea21499b811b9e74fe8792f1,

title = "Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study",

author = "Omer Linkovski and Wheaton, \{Michael G.\} and Jordana Zwerling and Zagaa Odgerel and \{Van Roessel\}, Peter and Maria Filippou-Frye and Anthony Lombardi and Brianna Wright and Steinman, \{Shari A.\} and Simpson, \{Helen Blair\} and Francis Lee and Rodriguez, \{Carolyn I.\}",

note = "Funding Information: This study was supported by the National Institutes of Mental Health [K23MH092434 (Dr Rodriguez) and K24MH09155 (Dr Simpson)], the Robert Wood Johnson Foundation [Harold Amos Medical Faculty Development Program (Dr Rodriguez)], the Black Family Foundation, and the New York State Psychiatric Institute.",

year = "2019",

month = jan,

day = "1",

doi = "10.1097/JCP.0000000000000994",

language = "אנגלית",

volume = "39",

pages = "91--93",

journal = "Journal of Clinical Psychopharmacology",

issn = "0271-0749",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

Linkovski, O, Wheaton, MG, Zwerling, J, Odgerel, Z, Van Roessel, P, Filippou-Frye, M, Lombardi, A, Wright, B, Steinman, SA, Simpson, HB, Lee, F & Rodriguez, CI 2019, 'Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study', Journal of Clinical Psychopharmacology, vol. 39, no. 1, pp. 91-93. https://doi.org/10.1097/JCP.0000000000000994

Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study. / Linkovski, Omer; Wheaton, Michael G.; Zwerling, Jordana et al.
In: Journal of Clinical Psychopharmacology, Vol. 39, No. 1, 01.01.2019, p. 91-93.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder

T2 - A Pilot Study

AU - Linkovski, Omer

AU - Wheaton, Michael G.

AU - Zwerling, Jordana

AU - Odgerel, Zagaa

AU - Van Roessel, Peter

AU - Filippou-Frye, Maria

AU - Lombardi, Anthony

AU - Wright, Brianna

AU - Steinman, Shari A.

AU - Simpson, Helen Blair

AU - Lee, Francis

AU - Rodriguez, Carolyn I.

N1 - Funding Information: This study was supported by the National Institutes of Mental Health [K23MH092434 (Dr Rodriguez) and K24MH09155 (Dr Simpson)], the Robert Wood Johnson Foundation [Harold Amos Medical Faculty Development Program (Dr Rodriguez)], the Black Family Foundation, and the New York State Psychiatric Institute.

PY - 2019/1/1

Y1 - 2019/1/1

UR - https://www.scopus.com/pages/publications/85058875864

U2 - 10.1097/JCP.0000000000000994

DO - 10.1097/JCP.0000000000000994

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 30531475

AN - SCOPUS:85058875864

SN - 0271-0749

VL - 39

SP - 91

EP - 93

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

IS - 1

ER -

Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study

Bibliographical note

Funding

UN SDGs

Access to Document

Other files and links

Cite this